Search results for: Multi-Indication Medicines
Filter search results
Approaches, Challenges and Successful Stories of Multi-indication Pricing in Europe
28 November 2018
Multi-Indication Pricing: Practical Solutions and Steps to Move Forward. A summary of an HTAi panel session. We have just published a new OHE Briefing entitled ‘Multi-Indication Pricing: Practical Solutions and…
Indication-Based Pricing: Are We All Onboard?
12 May 2020
…https://www.ohe.org/publications/multi-indication-pricing-mip-practical-solutions-and-steps-move-forward# Mestre-Ferrandiz,J., Towse, A., Dellamano, R., and Pistollato, M. (2015). Multi-indication Pricing: Pros, Cons and Applicability to the UK. Seminar Briefing 56. Office of Health Economics. Available at: https://www.ohe.org/publications/multi-indication-pricing-pros-cons-and-applicability-uk …
Indication-Based Pricing (IBP) Discussion Paper: Should drug prices differ by indication?
1 May 2019
Increasingly, scientific advances are delivering new medicines that deliver improved survival and quality of life across multiple treatment indications. Indication-Based Pricing (IBP) has been proposed as a way to better…
Indication-Based Pricing (IBP) Consultation Report
1 April 2020
…we pay for them. As more and more medicines come to market with multiple indications (or even more importantly the unrealised potentialto treat multiple indications), the way we pay for…
Economics of Innovative Payment Models Compared with Single Pricing of Pharmaceuticals
1 July 2018
The current system of a single price per medicine means that, for multi-indication medicines, the relationship between price and “value” can vary substantially. In this OHE Research paper, we consider:…
OHE Launches Discussion Paper and Consultation Exercise on Indication-based Pricing
10 May 2019
Increasingly, scientific advances are delivering new medicines that deliver improved survival and quality of life across multiple treatment indications. Indication-Based Pricing (IBP) has been proposed as a way to better…
What are the Economic Implications of Moving Away from Paying a Single Price for a Single Drug?
9 July 2018
…move to indication-based pricing would: (i) provide efficient R&D incentives which stimulate the development of new indications and greater access for patients, and (ii) increase price competition at indication-level, which…
Should Drug Prices Differ by Indication? The Debate on Indication-based Pricing
11 May 2018
…be achieved, when increasingly medicines are being developed that derive patient benefit across many different indications? Indication-based pricing (IBP) has been proposed as a way to tackle this issue, permitting…
The Debate on Indication-Based Pricing in the U.S. and Five Major European Countries
5 January 2018
…this be achieved, when increasingly medicines are being developed that derive patient benefit across many different indications? Indication-based pricing (IBP) has been proposed as a way to tackle this issue,…